BeOne Medicines AG (BEIGF)
OTCMKTS · Delayed Price · Currency is USD
24.92
0.00 (0.00%)
At close: Nov 10, 2025
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $37.42 billion as of January 16, 2026. Its market cap has increased by 90.28% in one year.
Market Cap
37.42B
Enterprise Value
34.41B
Revenue
4.97B
Ranking
n/a
PE Ratio
545.93
Stock Price
$24.92
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 858.74M to 37.42B, an increase of 4,257.92%. That is a compound annual growth rate of 46.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 37.42B | 11.32% |
| Dec 31, 2025 | 33.62B | 70.94% |
| Dec 31, 2024 | 19.67B | 4.69% |
| Dec 29, 2023 | 18.79B | -17.76% |
| Dec 30, 2022 | 22.84B | -17.96% |
| Dec 31, 2021 | 27.84B | 18.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 262.62M |